CUSIP 89854M101COMTCRXQ4 2025
42 filings · latest Aug 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 8.02M | $8.02M |
| 2 | Bvf Inc/Il | 5.23M | $5.23M |
| 3 | Baker Bros. Advisors LP | 2.78M | $2.78M |
| 4 | Vanguard Group Inc | 2.48M | $2.48M |
| 5 | Blackrock, Inc. | 1.85M | $1.85M |
| 6 | Aberdeen Group PLC | 1.79M | $1.79M |
| 7 | Deer Management Co. LLC | 1.25M | $1.25M |
| 8 | Renaissance Technologies LLC | 1.14M | $1.14M |
| 9 | Two Sigma Investments, LP |
| 4 | May 15, 2025 | Ecor1 Capital, LLC | 13G/A | 1.3% | — | SEC |
| 5 | May 15, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 5.26M | SEC |
| 6 | Apr 24, 2025 | Blackrock, Inc. | 13G/A | 5.4% | 2.83M | SEC |
| 7 | Feb 14, 2025 | K2 Healthventures Equity Trust LLC | 13G/A | 6.9% | 3.60M | SEC |
| 8 | Feb 14, 2025 | Lynx1 Capital Management LP | 13G/A | 10.9% | 5.36M | SEC |
| 9 | Feb 12, 2025 | Adage Capital Management, L.P. | 13G/A | 7.1% | 3.50M | SEC |
| 10 | Nov 14, 2024 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
See the full Schedule 13D/13G history for Tscan Therapeutics Inc.
Unlock full history| 651.2K |
| $651.2K |
| 10 | Dc Funds, LP | 630.0K | $630.0K |